Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Psoriasis Patient-Reported Survey Data | 2020

May 22, 2020

Only 15% of psoriasis patients feel controlled on their current treatment plan, according to new Health Union survey data from its online health community.

Fostering Confidence in Newly Diagnosed Autoimmune Patients

May 19, 2020

Survey data shows people newly diagnosed with an autoimmune condition report being less active and less confident in their treatment decisions.

Blood Cancer Patient-Reported Survey Data | 2020

May 15, 2020

58% of blood cancer patients feel satisfied with their current treatment plan, according to new Health Union survey data from its online health community.

Health Union Chief Community Officer Named to 2020 PM360 ELITE

May 8, 2020

Amrita Bhowmick, MPH, MBA has been named to the 2020 PM360 ELITE for her work in developing Health Union's online health community model.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities

June 28, 2018

Download the full free whitepaper, “#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities”

Expanding Patient Voices and Understanding Their Perspectives

Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap

June 27, 2018

There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.